The cGAS‐STING also promotes DC maturation and antitumor immunity.[16, 17] FCM data demonstrates that treatment with DMPtNPS@cGAMP + RT led to a 1.8‐fold increase in DC1s, a 2‐fold increase in mDCs, and 1.8‐fold increase in tumor‐infiltrating CD3+CD8+ T cells when compared to the DMPtNPS + RT group (Figure 7D–F). The gene discussed is CD8A; the disease is neoplasm.